Cargando…

Endocrine complications in patients with thalassaemia major

Detalles Bibliográficos
Autores principales:	Meng, Zhe, Liang, Liyang, Zhang, Lina, Hou, Liping, Liu, Zulin, Luo, Xiangyang, Fang, Jianpei, He, Zhanwen, Li, Dongfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850213/ http://dx.doi.org/10.1186/1687-9856-2013-S1-P55

Ejemplares similares

X-linked adrenoleukodystrophy in 8 patients
por: Meng, Zhe, et al.
Publicado: (2015)

The reproducibility of cardiac T2* measurement in thalassaemia major patients using bright and black blood sequences
por: Smith, Gillian, et al.
Publicado: (2009)

SUN-058 Endocrine and Metabolic Complications in 16 Taiwanese Patients with Thalassaemia Major
por: Lo, Fu-Sung
Publicado: (2020)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

Merosin-deficient congenital muscular dystrophy type 1A: A case report
por: HE, ZHANWEN, et al.
Publicado: (2013)

Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
por: Baldini, M., et al.
Publicado: (2014)

Endocrine responses to major abdominal surgery
por: Dimopoulou, I, et al.
Publicado: (2005)

Primary erythromelalgia mainly manifested by hypertensive crisis: A case report and literature review
por: Feng, Shuo, et al.
Publicado: (2022)

Endocrine complications in survivors of childhood medulloblastoma
por: Yuet-ling, Joanna Tung, et al.
Publicado: (2015)

5610480 TRANSFORMATION OF THALASSAEMIA GENETIC TESTING BY THE IMPLEMENTATION OF NGS-BASED THALASSEMIA ASSAY
por: Papasavva, T., et al.
Publicado: (2023)

5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.
por: Manganas, K.M., et al.
Publicado: (2023)

Osteoporosis Syndrome in Thalassaemia Major: An Overview
por: Toumba, Meropi, et al.
Publicado: (2010)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget, et al.
Publicado: (2014)

Worldwide survey of T2* cardiovascular magnetic resonance in Thalassaemia
por: Carpenter, John-Paul, et al.
Publicado: (2011)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Roles of endocrine FGF signaling in metabolic health and cancer
por: Luo, Yongde, et al.
Publicado: (2014)

Assertiveness in the patients with thalassaemia major: A qualitative study
por: Valizadeh, Leila, et al.
Publicado: (2021)

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures
por: Sun, Yi, et al.
Publicado: (2019)

Incidence of major complications related to endotracheal intubation in ICUs of nonacademic Brazilian public hospitals
por: Cavalcanti, AB, et al.
Publicado: (2013)

α-thalassaemia
por: Harteveld, Cornelis L, et al.
Publicado: (2010)

Completion of 5-year adjuvant endocrine therapy in the community
por: Makubate, B, et al.
Publicado: (2010)

Imaging diagnostic standard in multiple endocrine neoplasia (MEN)
por: Tesdorff, J, et al.
Publicado: (2014)

Producing and evaluating a novel lentiviral vector for β-thalassaemia gene therapy
por: Bokinni, Y, et al.
Publicado: (2012)

Clinical application of artificial intelligence in longitudinal image analysis of bone age among GHD patients
por: Zhang, Lina, et al.
Publicado: (2022)

MRI evaluation of tissue iron burden in patients with β-thalassaemia major
por: Argyropoulou, Maria I., et al.
Publicado: (2007)

Predictors of bone disease in Egyptian prepubertal children with β-thalassaemia major
por: Tantawy, Azza A.G., et al.
Publicado: (2010)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada, Francisco, et al.
Publicado: (2012)

Development and Validation of a Multidimensional Expectation Questionnaire for Thalassaemia Major Patients
por: Koutelekos, Ioannis G., et al.
Publicado: (2016)

Evaluation of Serum Leptin Levels and Growth in Patients with β-Thalassaemia Major
por: Al-Naama, Lamia Mustafa, et al.
Publicado: (2016)

Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition?
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Oocyte quality in women with thalassaemia major: insights from IVF cycles
por: Mensi, Laura, et al.
Publicado: (2019)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

Economic burden of adult patients with β-thalassaemia major in mainland China
por: Zhen, Xuemei, et al.
Publicado: (2023)

Marked exposure to the endocrine-disrupting chemicals phthalates and bisphenol A in the ICU
por: Huygh, J, et al.
Publicado: (2015)

Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen
por: Sun, Qixin, et al.
Publicado: (2018)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Screening for beta thalassaemia
por: Petrou, Mary
Publicado: (2010)

P105 Endocrine, autonomic and vascular function in children with Sleep Disordered Breathing
por: Noone, A, et al.
Publicado: (2021)

A multicenter study of endocrine abnormalities in septo-optic dysplasia (SOD) in Asean countries
por: Wacharasindhu, Suttipong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mtthsric2ugsc55r54or37fk7u